LIFETECH SCI.DL-00000125 (81X) — Capital Reinvestment Ratio

Latest as of December 2025: 0.27x

LIFETECH SCI.DL-00000125 (81X) has a Capital Reinvestment Ratio of 0.27x as of December 2025, meaning it reinvests 0% of its operating cash flow (€549.28 Million) in capital expenditures (€150.25 Million). See how leveraged is LIFETECH SCI.DL-00000125's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.27x
Capex / Operating Cash Flow

Operating Cash Flow

€549.28 Million
EUR

Capital Expenditures

€150.25 Million
EUR

Data as of

Dec 2025
Most recent filing

LIFETECH SCI.DL-00000125 Capital Reinvestment Ratio (2021–2025)

This chart tracks LIFETECH SCI.DL-00000125's Capital Reinvestment Ratio across 5 annual periods. Check LIFETECH SCI.DL-00000125 (81X) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for LIFETECH SCI.DL-00000125 (2021–2025)

Year-by-year Capital Reinvestment Ratio for LIFETECH SCI.DL-00000125 from 2021 to 2025. For live market cap and broader valuation context, see 81X company net worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.27x €549.28 Million €150.25 Million ▼ -68.9%
2024 0.88x €321.46 Million €283.00 Million ▲ +25.7%
2023 0.70x €418.05 Million €292.69 Million ▼ -19.0%
2022 0.86x €388.32 Million €335.47 Million ▲ +11.0%
2021 0.78x €441.09 Million €343.29 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow